LMEDD (LataMed AI) Shares Outstanding (EOP): 280.67 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMEDD LataMed AI Corp LMEDD
26 GF Score
Price $1.23
! 3 Warning Signs
View Full Analysis

What is LataMed AI Shares Outstanding (EOP)?

LataMed AI LMEDD +13.78% 26 Shares Outstanding (EOP) is 280.67 Mil as of Mar. 2026. GuruFocus rates LMEDD with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. LataMed AI's shares outstanding for the quarter that ended in Mar. 2026 was 280.67 Mil.

LataMed AI's quarterly shares outstanding increased from Dec. 2025 (221.48 Mil) to Mar. 2026 (280.67 Mil). It means LataMed AI issued new shares from Dec. 2025 to Mar. 2026 .

LataMed AI's annual shares outstanding increased from Dec. 2024 (146.38 Mil) to Dec. 2025 (221.48 Mil). It means LataMed AI issued new shares from Dec. 2024 to Dec. 2025 .


LataMed AI  (OTCPK:LMEDD) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


LataMed AI Shares Outstanding (EOP) Related Terms


LataMed AI Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for LataMed AI's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LataMed AI Shares Outstanding (EOP) Chart

LataMed AI Annual Data
Trend Dec23 Dec24 Dec25
Shares Outstanding (EOP)
1.22 146.38 221.48

LataMed AI Quarterly Data
Sep09 Sep10 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.38 146.38 146.38 221.48 280.67

LMEDD vs KLTR, BZAI, THRY: Shares Outstanding (EOP) Comparison

For the Software - Application subindustry, LataMed AI's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LataMed AI Shares Outstanding (EOP) vs Software Industry

For the Software industry and Technology sector, LataMed AI's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where LataMed AI's Shares Outstanding (EOP) falls into.


LMEDD
26GF Score
LataMed AI Corp LMEDD
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LataMed AI Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 280.67 Mil mean?
LataMed AI (LMEDD) has a Shares Outstanding (EOP) of 280.67 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on LataMed AI and its competitors.
Is LataMed AI's Shares Outstanding (EOP) too high?
LataMed AI's current Shares Outstanding (EOP) is 280.67 Mil. Overall, LataMed AI has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's Shares Outstanding (EOP) compare to KLTR and BZAI?
LataMed AI's Shares Outstanding (EOP) of 280.67 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Software company?
A good Shares Outstanding (EOP) depends on the Software industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on LataMed AI and its competitors. LataMed AI's current Shares Outstanding (EOP) is 280.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMEDD) has a current Shares Outstanding (EOP) of 280.67 Mil. The current Shares Outstanding (EOP) is 280.67 Mil. LataMed AI's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For LataMed AI (LMEDD), the current Shares Outstanding (EOP) is 280.67 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LataMed AI Business Description

Address Av. Romulo Gallegos con Av. Las Palmas, Edif. Torre Gerencial Los Andes, Caracas, VEN, 1071
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
26GF Score

Get the complete analysis for LMEDD

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.23
Price